Ironwood Pharmaceuticals, Inc. Maintains Earnings Guidance for the Fiscal Year 2023 and Provides Earnings Guidance for the Fiscal Year 2024
For the fiscal year 2024, the company expected total revenue of $435 million - $455 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.82 USD | -3.22% | -1.26% | -31.64% |
1st Jan change | Capi. | |
---|---|---|
-31.64% | 1.24B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |